What is the Purpose of Cancer Genetic Testing? How Accurate Are the Results?

According to research, approximately 50% of females and 33.3% of males have a chance of developing cancer in their lifetime, often without evident symptoms in the early stages. To facilitate early cancer detection, cancer genetic testing is a precise, safe, and reliable method.

What is the Purpose of Cancer Genetic Testing?

The human genome consists of approximately 20,000 genes, each carrying DNA sequences that contain genetic information. Each gene instructs various cells in the body to perform different tasks, ensuring the normal functioning of the body. However, if there are mutations in certain genes, it can increase the risk of developing cancer.

The purpose of cancer genetic testing is to detect potential risks at an early stage, allowing for timely treatment before the cancer progresses. This significantly improves the patient's chances of recovery and provides a more comfortable medical experience, while also saving considerable costs and time.

Typically, the process of cancer genetic testing involves a simple blood draw. Researchers analyze the DNA from the blood sample to determine if there are any genetic abnormalities, enabling a scientific assessment of the individual's cancer risk.

re:HEALTH’s Comprehensive Early Cancer Screening

LUCENCE INSIGHT Cancer Detection Achieves 90% Accuracy

re:HEALTH introduces the innovative LUCENCE INSIGHT™ Cancer Screening, which utilizes Next-Generation Sequencing (NGS) technology. With just one blood draw, it can simultaneously screen for eight high-risk cancers, including lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, nasopharyngeal cancer, bile duct cancer, and pancreatic cancer.

Furthermore, utilizing amplicon technology for cancer screening, the sensitivity reaches 73% and the specificity reaches 98.5%. Through genetic data analysis from the blood sample, it can detect and accurately identify cancer cell signals, predicting the origin of malignancy. The tumor tracing accuracy can reach as high as 90%!

It is recommended that individuals aged 40 and above, or those with a family history of hereditary cancers, consider genetic testing even in the absence of any cancer symptoms. This proactive approach helps prevent potential risks and allows for early intervention.

<Online Appointment>